Literature DB >> 7692770

Nitric oxide synthase inhibitor blocks spinal sensitization induced by formalin injection into the rat paw.

T Yamamoto1, N Shimoyama, T Mizuguchi.   

Abstract

This study evaluated the role of nitric oxide (NO) in spinal cord nociceptive transmission during peripheral inflammation evoked by formalin injection into the rat paw, using N omega-nitro-L-arginine (N-Arg), an NO synthase inhibitor. Male rats were prepared with intrathecal (IT) catheters. To quantify the formalin response, the instances of "flinching behavior" were counted at 5-min intervals for 60 min. IT N-Arg depressed the flinching behavior in a dose-dependent manner when N-Arg was administered 10 min before the formalin injection. This N-Arg effect was reversed with L-arginine but not D-arginine. We conclude that NO plays an important role in nociceptive transmission in the spinal cord during the formalin test.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7692770     DOI: 10.1213/00000539-199311000-00003

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  4 in total

1.  Evidence for tonic activation of NK-1 receptors during the second phase of the formalin test in the Rat.

Authors:  J L Henry; K Yashpal; G M Pitcher; J Chabot; T J Coderre
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

2.  Distribution of heme oxygenase-2 and NADPH-diaphorase in the spinal trigeminal nucleus of the rat.

Authors:  Wenguo Fan; Fang Huang; Weiguo Dong; Zhixiong Gao; Cuixia Li; Xiao Zhu; Dongpei Li; Hongwen He
Journal:  J Mol Histol       Date:  2009-10-11       Impact factor: 2.611

3.  Reduction of carrageenin oedema and the associated c-Fos expression in the rat lumbar spinal cord by nitric oxide synthase inhibitor.

Authors:  P Honoré; V Chapman; J Buritova; J M Besson
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

4.  Formalin injection causes a coordinated spinal cord CO/NO-cGMP signaling system response.

Authors:  Xiaoyou Shi; Xiangqi Li; J David Clark
Journal:  Mol Pain       Date:  2005-11-18       Impact factor: 3.395

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.